Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Apr 19, 2012 baker charles a Director Automatic Sell 12,910 125.00
Apr 19, 2012 baker charles a Director Option Execute 12,910 18.80
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 6, 2012 baker charles a Director Automatic Sell 13,714 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Sep 6, 2012 baker charles a Director Option Execute 13,714 15.01
Nov 26, 2012 baker charles a Director Automatic Sell 15,000 171.45 - 175.14
Nov 26, 2012 baker charles a Director Option Execute 15,000 9.17
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
May 15, 2013 brown michael s Director Sell 10,000 278.28
May 17, 2013 brown michael s Director Sell 5,000 269.00 - 270.20
May 15, 2013 brown michael s Director Option Execute 15,000 24.41
Mar 21, 2013 brown michael s Director Automatic Sell 15,000 172.61 - 174.13
Mar 21, 2013 brown michael s Director Option Execute 15,000 18.61
Oct 25, 2012 brown michael s Director Sell 2,000 155.34
Oct 26, 2012 brown michael s Director Sell 3,000 154.69
Oct 25, 2012 brown michael s Director Option Execute 2,000 23.84
Oct 26, 2012 brown michael s Director Option Execute 3,000 23.84
Nov 14, 2012 brown michael s Director Sell 7,000 147.03
Showing 41-60 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)